Business
Press Release Mar 10 2023
Marksans Pharma Limited has informed the Exchange regarding a press release dated March 10, 2023, titled "Marksans Pharma Limited announces US FDA approval for Famotidine Tablets USP, 10 mg and 20 mg.".
About this update from Marksans Pharma Limited
[{"type":"text","content":" Marksans Pharma Limited has informed the Exchange regarding a press release dated March 10, 2023, titled \"Marksans Pharma Limited announces US FDA approval for Famotidine Tablets USP, 10 mg and 20 mg.\". View Attachment","length":350,"tagName":"div"}]